These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Insulin antibodies in diabetics receiving a single type of insulin. Mincu I; Cheţa D Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of insulin antibodies in insulin treated patients. Giampietro O; Giannessi D; Del Chicca MG; Luche AD; Zucchelli GC; Navalesi R J Nucl Med Allied Sci; 1980; 24(3-4):153-8. PubMed ID: 7019394 [No Abstract] [Full Text] [Related]
30. [Antibodies to insulin in diabetes mellitus]. Liashko KIa; Mikhaĭlova VS; Dreval' AV Ter Arkh; 1971 Dec; 43(12):68-71. PubMed ID: 5140364 [No Abstract] [Full Text] [Related]
31. [Insulin immunogenicity and its various clinical aspects]. Rogala H Pol Tyg Lek; 1983 Jan; 38(4):127-30. PubMed ID: 6344050 [No Abstract] [Full Text] [Related]
32. [Changes of insulin antibody binding ability during monocomponent insulin therapy]. Araki S; Sasai T; Shichiri M; Yoshikawa R; Hoshi M Horumon To Rinsho; 1977 Jan; 25(1):55-60. PubMed ID: 557390 [No Abstract] [Full Text] [Related]
33. [Determination of the insulin antibody titre in severe form of diabetes mellitus]. Pliats OM; Alekseev IuP Probl Endokrinol (Mosk); 1977; 23(3):12-4. PubMed ID: 887624 [TBL] [Abstract][Full Text] [Related]
34. Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics. Irvine WJ; Al-Khateeb SF; Di Mario U; Feek CM; Gray RS; Edmond B; Duncan LJ Clin Exp Immunol; 1977 Oct; 30(1):16-21. PubMed ID: 606435 [TBL] [Abstract][Full Text] [Related]
35. [Immunologic tolerance against insulin. A therapeutic goal to prevent immunological complications in the diabetic patient using insulin]. Jansen FK Med Welt; 1972 Nov; 23(48):1818-9. PubMed ID: 4654716 [No Abstract] [Full Text] [Related]
36. Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients. Emanuelli G; Gatti G; Calcamuggi G; Anfossi G; Cotto A; Marcarino C; Camussi G; Ottone G Panminerva Med; 1981; 23(2):81-8. PubMed ID: 7033894 [No Abstract] [Full Text] [Related]
37. The prevalence of proinsulin-specific antibodies in diabetic patients. Kumar D; Miller LV Horm Metab Res; 1973 Jan; 5(1):1-3. PubMed ID: 4735948 [No Abstract] [Full Text] [Related]
38. Insulin antibodies and the control of diabetes. Dixon K; Exon PD; Malins JM Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646 [TBL] [Abstract][Full Text] [Related]
40. A method for determination of anti-insulin antibodies in the plasma of insulin-treated diabetics. Sekso M; Resetić J; Riznar V; Solter M Acta Med Iugosl; 1978; 32(2):125-34. PubMed ID: 665291 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]